EMEA (Europe, Middle East and Africa) Pemetrexed Diacid Market Report 2018

Published - Apr 2018 | Category - Chemical & Material | No. of Pages - 112 | Published By - Global QYResearch

Report Highlights

In this report, the EMEA Pemetrexed Diacid market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Pemetrexed Diacid for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pemetrexed Diacid market competition by top manufacturers/players, with Pemetrexed Diacid sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly and Company
Natco Pharma Ltd
United Biotech India Pvt.Ltd.
Actiza Parma
Beacon Pharma
Chemotherapy
Onkos
Emcure
Cytotoxic
Pemgem
Lianyungang Tengfa Bio-tech Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd.
Qilu Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
100mg Injection
200mg Injection
300mg Injection
500mg Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Mesothelioma
Non-Small Cell Lung Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Quick Buy

Latest Publications